445 related articles for article (PubMed ID: 16901280)
1. Cytotoxic CD4 T cells in viral hepatitis.
Aslan N; Yurdaydin C; Wiegand J; Greten T; Ciner A; Meyer MF; Heiken H; Kuhlmann B; Kaiser T; Bozkaya H; Tillmann HL; Bozdayi AM; Manns MP; Wedemeyer H
J Viral Hepat; 2006 Aug; 13(8):505-14. PubMed ID: 16901280
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
Stone SF; Price P; French MA
HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of dysfunctional effector CD8+ T cells in the liver of patients with chronic HCV infection.
Nisii C; Tempestilli M; Agrati C; Poccia F; Tocci G; Longo MA; D'Offizi G; Tersigni R; Lo Iacono O; Antonucci G; Oliva A
J Hepatol; 2006 Mar; 44(3):475-83. PubMed ID: 16426698
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of perforin expression in human CD4+ and CD8+ cytotoxic T lymphocytes.
Niiya H; Sakai I; Lei J; Azuma T; Uchida N; Yakushijin Y; Hato T; Fujita S; Yasukawa M
Exp Hematol; 2005 Jul; 33(7):811-8. PubMed ID: 15963857
[TBL] [Abstract][Full Text] [Related]
6. Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment.
Kvale D; Ormaasen V; Kran AM; Johansson CC; Aukrust P; Aandahl EM; Frøland SS; Taskén K
AIDS; 2006 Apr; 20(6):813-20. PubMed ID: 16549964
[TBL] [Abstract][Full Text] [Related]
7. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
[TBL] [Abstract][Full Text] [Related]
8. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages.
Rosen HR; Miner C; Sasaki AW; Lewinsohn DM; Conrad AJ; Bakke A; Bouwer HG; Hinrichs DJ
Hepatology; 2002 Jan; 35(1):190-8. PubMed ID: 11786976
[TBL] [Abstract][Full Text] [Related]
9. Characterization of CD8+ T lymphocytes in chronic HIV-1 subtype A infection in Rwandan women.
Jiang Y; Karita E; Castor D; Jolly PE
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51 Suppl():OL737-43. PubMed ID: 16171573
[TBL] [Abstract][Full Text] [Related]
10. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.
Migueles SA; Laborico AC; Shupert WL; Sabbaghian MS; Rabin R; Hallahan CW; Van Baarle D; Kostense S; Miedema F; McLaughlin M; Ehler L; Metcalf J; Liu S; Connors M
Nat Immunol; 2002 Nov; 3(11):1061-8. PubMed ID: 12368910
[TBL] [Abstract][Full Text] [Related]
11. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
[TBL] [Abstract][Full Text] [Related]
12. Perforin hyperreleasability and depletion in cytotoxic T cells from patients with exacerbated atopic dermatitis and asymptomatic rhinoconjunctivitis allergica.
Ambach A; Bonnekoh B; Gollnick H
J Allergy Clin Immunol; 2001 May; 107(5):878-86. PubMed ID: 11344356
[TBL] [Abstract][Full Text] [Related]
13. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism in the proximal promoter region of the perforin gene and its impact on the course of HIV infection.
McIlroy D; Meyer L; Dudoit Y; Samri A; Delfraissy JF; Autran B; Debré P; Theodorou I
Int J Immunogenet; 2006 Apr; 33(2):73-9. PubMed ID: 16611250
[TBL] [Abstract][Full Text] [Related]
15. Characterization of virus-specific CD8(+) effector T cells in the course of HIV-1 infection: longitudinal analyses in slow and rapid progressors.
Jansen CA; Piriou E; Bronke C; Vingerhoed J; Kostense S; van Baarle D; Miedema F
Clin Immunol; 2004 Dec; 113(3):299-309. PubMed ID: 15507395
[TBL] [Abstract][Full Text] [Related]
16. Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines.
Miskovsky EP; Liu AY; Pavlat W; Viveen R; Stanhope PE; Finzi D; Fox WM; Hruban RH; Podack ER; Siliciano RF
J Immunol; 1994 Sep; 153(6):2787-99. PubMed ID: 7915742
[TBL] [Abstract][Full Text] [Related]
17. CD8+HLA-DR+ T lymphocytes are increased in common variable immunodeficiency patients with impaired memory B-cell differentiation.
Viallard JF; Blanco P; André M; Etienne G; Liferman F; Neau D; Vidal E; Moreau JF; Pellegrin JL
Clin Immunol; 2006 Apr; 119(1):51-8. PubMed ID: 16413828
[TBL] [Abstract][Full Text] [Related]
18. Preservation of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses despite global loss of CD4+ T cells in HCV/HIV coinfection.
Morishima C; Shuhart MC; Yoshihara CS; Paschal DM; Silva MA; Thomassen LV; Emerson SS; Gretch DR
J Infect Dis; 2007 Aug; 196(4):577-86. PubMed ID: 17624844
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
20. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
